Master Fund Ltd. Nisswa Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Master Nisswa IGC stock SEC Form 4 insiders trading

Master has made over 1 trades of the IGC Pharma Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently Master sold 11,447 units of IGC stock worth $66,965 on 22 February 2008.

The largest trade Master's ever made was selling 11,447 units of IGC Pharma Inc stock on 22 February 2008 worth over $66,965. On average, Master trades about 3,816 units every 0 days since 2008.

You can see the complete history of Master Nisswa stock trades at the bottom of the page.

What's Master Nisswa's mailing address?

Master's mailing address filed with the SEC is C/O PINE RIVER CAPITAL MANAGEMENT L.P., 601 CARLSON PARKWAY, SUITE 330, MINNETONKA, MN, 55305.

Insiders trading at IGC Pharma Inc

Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira et Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.

What does IGC Pharma Inc do?

igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments

Complete history of Master Nisswa stock trades at Information Services et IGC Pharma Inc

IGC Pharma Inc executives and stock owners

IGC Pharma Inc executives and other stock owners filed with the SEC include:

• Ram Mukunda,
  Exec. Chairman, Pres & CEO
• Claudia Grimaldi,
  Vice President, Principal Financial Officer
• Claudia Grimaldi,
  VP & Principal Financial Officer
• Richard Prins,
  Independent Chairman of the Board
• Rohit Goel,
  Manager and Principal Accounting Officer
• Dr. Ranga C. Krishna M.D.,
  Sr. Advisor
• Parveen Mukunda,
  Corp. Sec.
• Rohit Goel,
  Sr. Director of Accounting & Principal Accounting Officer
• John Edward Lynch,
  Director
• John Cherin,
  CFO, Treasurer and PAO
• Sudhakar V Shenoy,
  Director
• Ranga C Krishna,
  Director
• Terry L Lierman,
  Director
• Shu Kwong Ngai,
  Interim CFO
• Zwirn & Co., L.P.Zwirn Dani...,
  
• Acquisition Master Fund Ltd...,
  10% owner
• Suhail Nathani,
  Director
• Ag Ubs,
  10% owner
• Steven Michael Oliveira,
  10% owner
• Master Fund Ltd. Nisswa,
  10% owner
• Ram Mukunda,
  CEO
• Strategic Investment Fund A...,
  10% owner
• James P Moran,
  Director